These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
280 related articles for article (PubMed ID: 752036)
1. Abnormal response of pancreatic glucagon to glycemic changes in diabetes mellitus. Ohneda A; Watanabe K; Horigome K; Sakai T; Kai Y; Oikawa S J Clin Endocrinol Metab; 1978 Mar; 46(3):504-10. PubMed ID: 752036 [TBL] [Abstract][Full Text] [Related]
2. Comparison of the suppressive effects of elevated plasma glucose and free fatty acid levels on glucagon secretion in normal and insulin-dependent diabetic subjects. Evidence for selective alpha-cell insensitivity to glucose in diabetes mellitus. Gerich JE; Langlois M; Noacco C; Lorenzi M; Karam JH; Korsham PH J Clin Invest; 1976 Aug; 58(2):320-5. PubMed ID: 783198 [TBL] [Abstract][Full Text] [Related]
3. Studies on the pathogenesis of reactive hypoglycemia: role of insulin and glucagon. Lefebvre PJ; Luyckx AS; Lecomte MJ Horm Metab Res; 1976; Suppl 6():91-8. PubMed ID: 1278843 [TBL] [Abstract][Full Text] [Related]
4. Glucose, insulin and glucagon in the diabetic goose. Karmann H; Mialhe P Horm Metab Res; 1976 Nov; 8(6):419-26. PubMed ID: 1002101 [TBL] [Abstract][Full Text] [Related]
5. Fasting hyperglycemia impairs glucose- but not insulin-mediated suppression of glucagon secretion. Abdul-Ghani M; DeFronzo RA J Clin Endocrinol Metab; 2007 May; 92(5):1778-84. PubMed ID: 17327375 [TBL] [Abstract][Full Text] [Related]
7. Glucagon response to arginine after treatment of diabetes mellitus. Ohneda A; Ishii S; Horigome K; Yamagata S Diabetes; 1975 Sep; 24(9):811-9. PubMed ID: 1158041 [TBL] [Abstract][Full Text] [Related]
8. Impact of glucagon response on postprandial hyperglycemia in men with impaired glucose tolerance and type 2 diabetes mellitus. Henkel E; Menschikowski M; Koehler C; Leonhardt W; Hanefeld M Metabolism; 2005 Sep; 54(9):1168-73. PubMed ID: 16125528 [TBL] [Abstract][Full Text] [Related]
9. Elevated plasma levels of glucagon-like peptide-1 after oral glucose ingestion in patients with pancreatic diabetes. Hiroyoshi M; Tateishi K; Yasunami Y; Maeshiro K; Ono J; Matsuoka Y; Ikeda S Am J Gastroenterol; 1999 Apr; 94(4):976-81. PubMed ID: 10201468 [TBL] [Abstract][Full Text] [Related]
10. Glucagon secretion in subjects with prediabetes, diabetes mellitus and obesity. Slavnov VN; Epshtein EV; Efimov AS; Malinkovich VD; Stepanenko LI Endocrinologie; 1979; 17(3):213-8. PubMed ID: 504963 [TBL] [Abstract][Full Text] [Related]
11. Intrapulmonary administration of natural honey solution, hyperosmolar dextrose or hypoosmolar distill water to normal individuals and to patients with type-2 diabetes mellitus or hypertension: their effects on blood glucose level, plasma insulin and C-peptide, blood pressure and peaked expiratory flow rate. Al-Waili N Eur J Med Res; 2003 Jul; 8(7):295-303. PubMed ID: 12911866 [TBL] [Abstract][Full Text] [Related]
12. Reduced glucose tolerance and insulin resistance induced by steroid treatment, relative physical inactivity, and high-calorie diet impairs the incretin effect in healthy subjects. Hansen KB; Vilsbøll T; Bagger JI; Holst JJ; Knop FK J Clin Endocrinol Metab; 2010 Jul; 95(7):3309-17. PubMed ID: 20410219 [TBL] [Abstract][Full Text] [Related]
13. Role of GLP-1 induced glucagon suppression in type 2 diabetes mellitus. Hare KJ Dan Med Bull; 2010 Sep; 57(9):B4181. PubMed ID: 20816021 [TBL] [Abstract][Full Text] [Related]
14. Hyperglucagonemia and blood glucose regulation in normal, obese and diabetic subjects. Sherwin RS; Fisher M; Hendler R; Felig P N Engl J Med; 1976 Feb; 294(9):455-61. PubMed ID: 1246330 [TBL] [Abstract][Full Text] [Related]
15. [Changes in the glucagon and growth hormone levels in the blood plasma of healthy persons and of patients with disordered glucose tolerance after insulin administration]. Tikhonova NE; Alekseeva GG Probl Endokrinol (Mosk); 1986; 32(1):22-5. PubMed ID: 3513155 [TBL] [Abstract][Full Text] [Related]
16. High dose intravenous glucose tolerance test and serum insulin and glucagon levels in diabetic and non-diabetic cats: relationships to insular amyloidosis. O'Brien TD; Hayden DW; Johnson KH; Stevens JB Vet Pathol; 1985 May; 22(3):250-61. PubMed ID: 3890345 [TBL] [Abstract][Full Text] [Related]
17. Decreased hypoglycemic effect of insulin at night in insulin-dependent diabetes mellitus and healthy subjects. Garrel DR; Bajard L; Harfouche M; Tourniaire J J Clin Endocrinol Metab; 1992 Jul; 75(1):106-9. PubMed ID: 1618996 [TBL] [Abstract][Full Text] [Related]
18. Glucagon-induced insulin secretion in normal diabetic subjects. Ohneda A; Matsuda K; Chiba M; Iimura Y; Yamagata S Tohoku J Exp Med; 1975 Jun; 116(2):103-10. PubMed ID: 1154379 [TBL] [Abstract][Full Text] [Related]
19. Influence of continuous physiologic hyperinsulinemia on glucose kinetics and counterregulatory hormones in normal and diabetic humans. SaccĂ L; Sherwin R; Hendler R; Felig P J Clin Invest; 1979 May; 63(5):849-57. PubMed ID: 447832 [TBL] [Abstract][Full Text] [Related]
20. Effects of somatostatin on plasma glucose and glucagon levels in human diabetes mellitus. Pathophysiologic and therapeutic implications. Gerich JE; Lorenzi M; Schneider V; Karam JH; Rivier J; Guillemin R; Forsham PH N Engl J Med; 1974 Sep; 291(11):544-7. PubMed ID: 4604408 [No Abstract] [Full Text] [Related] [Next] [New Search]